The european experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: A retrospective multi-centre study

European Journal of Cardio-thoracic Surgery

Volumn 15, Issue 6, 1999, Pages 835-841

  El Banayosy, A ^a   Deng, M ^b   Loisance, D Y ^c   Vetter, H ^d   Gronda, E ^e   Loebe, M ^f   Vigano, M ^g  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c HENRI MONDOR HOSPITAL   (France)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^g FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Bridge to transplant; Left ventricular assist therapy

Indexed keywords

ADOLESCENT; AGED; ARTICLE; ARTIFICIAL HEART; CLINICAL TRIAL; EVALUATION; FEMALE; HEART ASSIST DEVICE; HEART RIGHT VENTRICLE FAILURE; HUMAN; INFECTION RISK; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROSTHESIS; PROSTHESIS FAILURE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; EUROPE; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0032799761     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(99)00107-4     Document Type: Article

References (21)

1. Task Force on Heart Failure of the European Society of Cardiology: Guidelines for the diagnosis of heart failure. Eur Heart J. 1995:1995;741-751.
2. Garg R., Yusuf S. Epidemiology of congestive heart failure. Barnett D.B., Poleur H., Francis G.S. Congestive cardiac failure: pathophysiology and treatment. 1993;9 Marcel Dekker, New York.
3. Ho K.K., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 22:(4 Suppl A):1993;6A-13A.
4. Euro Transplant International Foundation, Leiden, Netherlands.
5. Hosenpud J.D., Novick R.J., Bennett L.E., Keck B.M., Fiol B., Daily P. The registry of the International Society of Heart and Lung Transplantation: thirteenth official report. J Heart Lung Transplant. 15:1996;655-674.
6. Lough M.E., Lindsey A.M., Shinn J.A., Stotts N.A. Impact of symptom frequency and symptom distress on self-reported quality of life in heart transplant recipients. J. Heart Lung. 16:1987;193.
7. DeVries W.C., Anderson J.L., Joyce L.D., Anderson F.L., Hammond E.H., Jarvik R.K., Kolff W.J. Clinical use of the total artificial heart. New Engl J Med. 310:1984;273-278.
8. Statement on Jarvik Artificial Heart. Rockville, MD: FDA Press Office, 11 January 1990.
9. Fey O., El-Banayosy A., Arosuglu L., Posival H., Korfer R. Out-of-hospital experience in patients with implantable mechanical circulatory support: present and future trends. Eur J Cardiothorac Surg. (11 Suppl):1997;S51-S53.
10. Portner P.M., Oyer P.E., McGregor C.G.A., Baldwin J.C., Ream A.K., Wyner J., Zusman D.R., Shumway N.E. First human use of an electrically powered implantable ventricular assist system. Artif Organs. 9:1985;36.
11. Vigano M., Martinelli L. Modified method for Novacor left ventricular assist device implantation. Ann Thorac Surg. 61:1996;247-249.
12. Muller J., Wallukat G., Weng Y-G., Dandel M., Spiegelsberger S., Semrau S., Brandes K., Theodoris V., Loebe M., Meyer R., Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 96:1997;542-549.
13. Loisance D., Cooper G.J., Deleuze P.H. Bridge to transplantation with the wearable Novacor left ventricular assist system: operative technique. Eur J Cardiothorac Surg. 9:1995;95-98.
14. Vetter H.O., Kaulbach H.G., Schmitz C., Forst H., Uberfuhr P., Kreuzer E., Pfeiffer M., Brenner P., Dewald O., Reichart B. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system. J Thorac Cardiovasc Surg. 109:1995;74-80.
15. Herman M., Weyand M., Greshake B., von Eiff C., Proctor R.A., Scheld H.H., Peters G. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplant. Circulation. 95:1997;814-817.
16. Novacor FDA submission, 1998.
17. Delgado R., Radovancevic B., Massin E.K., Frazier O.H., Benedict C. Neurohormonal changes after implantation of a left ventricular assist system. ASAIO J. 44:1998;299-302.
18. Mehta S.M., Pae W. Erosion of inlet cannula of left ventricular assist device manifested as innocuos bleeding in a stable patient: lessons learned in the prevention of catastrophic consequences. J Thorac Cardiovasc Surg. 112:1996;544-545.
19. Mehta S.M., Aufiero T.X., Pae W.E., Miller C.A., Pierce W.S. Combined registry for the use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: sixth official report. J Heart Lung Transplant. 14:1995;585-593.
20. Scheld H.H., Soeparwata R., Schmid C., Loick M., Weyand M., Hammel D. Rupture of inflow conduits in the TCI Heartmate system. J Thorac Cardiovasc Surg. 114:1997;287-289.
21. Loisance D., Tixier D., Mazzucotelli J.P., Deleuze P.H., Baufreton C., Le Besnerais P. Mechanical circulatory support towards the permanent implantation. Eur J Cardiothorac Surg. (11 Suppl):1997;S25-S28.